Parse Biosciences

Parse Biosciences is a Seattle-based biotechnology company founded in 2018, specializing in scalable, instrument-free single-cell sequencing solutions. The company is known for its proprietary Evercode™ platform, which enhances high-throughput RNA workflows. With around 110 employees, Parse serves over 3,000 customers in more than 40 countries, focusing on advancing single-cell science through innovative combinatorial barcoding technology. The company provides a range of end-to-end solutions, including Evercode™ Whole Transcriptome Kits for scalable single-cell RNA sequencing, Evercode™ Immune Profiling assays for immunological applications, and the Trailmaker™ Software Suite for cloud-based data analysis. Additionally, the GigaLab service platform supports large-scale project processing. Parse's tools are designed to be flexible and accessible, enabling researchers to explore complex biological systems across various fields, including developmental biology, cancer research, and immunotherapy.